Since the ERK pathway has been reported to promote epithelial to mesenchymal transition (EMT) [30], we further examined the expression of EMT-related proteins in lung cancer cells with CD44 knockdown and overexpression. This evidence concerns the gene CD44 and lung carcinoma.